1. FletcherAP, GriffinJP. International monitoring for adverse drug reactions of long latency.Adverse Drug React Toxicol Rev 1991;10: 209–30.
2. IARC Monogr Eval Carcinog Risks Hum;International Agency for Research on Cancer,1990
3. HutchinsonJ. Arsenic cancer.BMJ 1887;3: 1280–1.
4. BoivinJF, HutchinsonGB. Second cancers after treatment for Hodgkin's disease: a review. In BoiceJDJr, FraumeniJFJr, eds.Radiation Carcinogenesis: Epidemiology and Biological Significance. Progress in Cancer Research and Therapy, Vol. 26. New York, NY (USA): Raven Press, 1984: 181–98.
5. FisherB, RochetteH, FisherER, WiekerhamDL, RedmondC, BrownA. Leukemia in breast cancer patients following adjuvant chemotherapy or postoperative radiation: the NSABP experience.J Clin Oncol 1985;3: 1640–58